Furthermore, upregulation of CCNB1 along with other cell-cycle genes indicates poor survival in various cancers [33], and upregulation of CCNB1 alone is suggested to be a marker for a poor prognosis in breast cancer [34], making CCNB1 an interesting target candidate also in GBM. This evidence concerns the gene CCNB1 and cancer.